| Literature DB >> 18203429 |
Y Z Zhang1, B Su, J Venugopal, S Ramakrishna, C T Lim.
Abstract
Electrospinning is an enabling technology that can architecturally (in terms of geometry, morphology or topography) and biochemically fabricate engineered cellular scaffolds that mimic the native extracellular matrix (ECM). This is especially important and forms one of the essential paradigms in the area of tissue engineering. While biomimesis of the physical dimensions of native ECM's major constituents (eg, collagen) is no longer a fabrication-related challenge in tissue engineering research, conveying bioactivity to electrospun nanofibrous structures will determine the efficiency of utilizing electrospun nanofibers for regenerating biologically functional tissues. This can certainly be achieved through developing composite nanofibers. This article gives a brief overview on the current development and application status of employing electrospun composite nanofibers for constructing biomimetic and bioactive tissue scaffolds. Considering that composites consist of at least two material components and phases, this review details three different configurations of nanofibrous composite structures by using hybridizing basic binary material systems as example. These are components blended composite nanofiber, core-shell structured composite nanofiber, and nanofibrous mingled structure.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18203429 PMCID: PMC2676814
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1Schematic cross-sectional views of different structures of composite nanofibers from components of A and B. (a) randomly blended; (b) core-shell structured; and (c) nanofibers-mingled (from concurrent electrospinning).
Organic–organic blend composite nanofibrous scaffolds
| DNA/PLGA or PLA– PEG block copolymer | DMF/Tris–EDTA buffer | 250–875 nm, 375 nm–1.1μm | A pre–osteoblastic cell line, MC3T3E1 | Bone | ( |
| Gelatin/PCL | TFE | 500–900 nm | BMSCs, Fibroblasts | Skin | ( |
| Collagen/PEUU | HFIP | 100–900 nm | smooth muscle cells | Soft tissues | ( |
| Collagen/Elastin/PEO | Aqueous HCl | 220–600 nm | SMCs | Blood vessel | ( |
| PLCL/Collagen (or Heparin) | HFIP | 120–520 nm | HUVEC | Vascular graft | ( |
| NGF–BSA/PCLEEP | DCM/PBS | 0.5~3.0μm | PC12 cells | Nerve | ( |
| Collagen/GAG(eg, CS) | TFE/Water | 260 nm | RCFs | / | ( |
| Collagen/Elastin/PLGA (blend ratio 45:15:40) | HFIP | 720 ± 350 nm | Bovine endothelial and smooth muscle cells | Vascular substitute | ( |
| Gelatin/PANi | HFIP | 60–800 nm | H9c2 rat cardiac myoblast | Cardiac/nerve | ( |
| Gelatin/Elastin/PLGA | HFIP | 380 ± 80 nm | H9c2 rat cardiac myoblast, BSCs | Heart/blood vessel | ( |
| Collagen/P(LLA–CL) | HFIP | 100–300 nm | HCAECs | Blood vessel | ( |
| PGA/Chitin | HFIP | 50–350 nm | Fibroblasts | / | ( |
| PHBV/Collagen | HFIP | 300–600 nm | NIH3T3 | / | ( |
| PDO/Elastin | HFIP | 400–800 nm | Human dermal fibroblasts | Vascular graft | ( |
| GDNF/PCLEEP | DCM/PBS | 3.96 ± 0.14μm | Nerve | ( | |
| Collagen/PCL | HFIP | ~275 nm | HDFs | Skin | ( |
| Collagen/PCL (75:25) | HFIP | 541 ± 164 nm | Schwann cells, fibroblasts, olfactory ensheathing cells | Nerve | ( |
Abbreviations: BMSC: bone marrow stromal cell; BSA, bovine serum albumin; CS, chondroitin sulfate; DCM, dichloromethane; DMF, dimethylformamide; GAG, glycos-aminoglycan; GDNF, human glial cell–derived neurotrophic factor; HCAEC, human coronary artery endothelial cell; HCl, hydrochloric acid; HDF, human dermal fibroblast; hESF, human embryo skin fibroblast; HUVEC, human umbilical vein endothelial cell; HFIP, hexafluoroisopropanol; NGF, nerve growth factor; P(LLA–CL), poly(L–lactic acid)–co–poly(ɛ–caprolactone); PANi, polyaniline; PBS, phosphate buffered saline; PCL, poly(ɛ–caprolactone); PCLEEP, polymer(ɛ–caprolactone–co–ethylethylene phosphate); PDO, polydioxanone; PEG, poly(ethylene glycol); PEO, poly(ethylene oxide); PEUU, poly(ester urethane)urea; PGA, poly(glycolic acid); PHBV, poly(3–hydroxybutyrate–co–3–hydroxyvalerate); PLA, polylactide; PLCL, poly(L–lactide–co–ɛ–caprolactone); PLGA, poly (D,L–lactide–co–glycolide); PlnDI, perlecan domain I; PVA, poly(vinyl alcohol); RCF, rabbit conjunctiva fibroblast; SMC, Smooth muscle cell; TFE, trifluoroethanol.
Figure 2SEM images of 3-D porous fibers (a) after gelatin was leached out of the electrospun Gt/PCL composite fibers (b) (Zhang, Feng et al 2006). Scale bar 2 μm.
Organic – inorganic blend composite nanofibrous scaffolds
| HA/Gelatin | HFIP | 200–400 nm | human osteoblastic cells MG63 | bone | ( |
| PCL/CaCO3 | Chloroform/Methanol | 760 ± 190 nm | human osteoblast hFOB1.19 | bone | ( |
| PHBV/HAp | TFE | 100–2,000 nm | COS– 7 cells from the monkey kidney | / | ( |
| HA/PLA | Chloroform | 1~2 μm | MG63 cells | bone | ( |
| Silk/PEO/nHAP/BMP– 2 | water | 520 ± 55 nm | hMSCs | bone | ( |
| PLLA/HA | DCM/1,4-dioxane | <500 nm | human osteosarcoma MG– 63 | bone | ( |
| PCL/HA/Collagen | HFIP | 373 ± 191 nm | hFOB | bone | ( |
| PLLA/MWCNT/HA | DCM | 250–950 nm | DPSCs | dental | ( |
Abbreviations: BMP– 2, bone morphogenetic protein 2; CaCO3, calcium carbonate; DCM, dichloromethane; DPSC, dental pulp stem cell; HA/nHAP/HAp, hydroxyapatite; HFIP, hexafluoroisopropanol; hFOB, human fetal osteoblasts; hMSC, human bone marrow– derived mesenchymal stem cell; MWCNT, multi– wall carbon nanotube; PHBV, poly(3– hydroxybutyrate– co– 3– hydroxyvalerate); PLLA, poly(L– lactic acid); PCL, poly(ɛ– caprolactone); PEO, poly(ethylene oxide); PLA, polylactide; TFE, trifluoroethanol.
Figure 3Illustrated cross-sectional views of a variety of novel and functional polymeric nanofibers from coaxial electrospinning, including basic bi-component nanofiber, surface coated/modified nanofiber through tuning the sheath thickness, nanoparticles encapsulated nanocomposite nanofiber, and hollow nanofibers where the core component is removed.
Figure 4Coaxial electrospinning were employed to develop core-shell nanofibers (a) (Zhang, Huang et al 2004), self-assembled FePt magnetic nanoparticles (ca. 4 nm) encapsulated nanofibers (b) (Song, Zhang et al 2005), hollow nanofibers (c) (Li and Xia 2004), and multichannel tubes (d) (Zhao, Cao et al 2007).
Figure 5Core-shell structured collagen-r-PCL nanofibers favored HDFs proliferation (a) and cellular infiltration (b) (Zhang, Venugopal et al 2005).
Core-shell structured nanofiber scaffolds
| Collagen-r-PCL | TFE | 385 ± 82 nm | Fibroblasts | Skin | ( |
| Collagen-P(LLA-CL) | Aqueous HCl, DCM/DMF | 470 ± 130 nm | HCAECs | Vascular graft | ( |
| Gelatin-[PMAA]-PET | TFA | 200–600 nm | Endothelial cells | Blood vessel | ( |
| Galactose -[PAAc]- PCLEEP | Acetone | 760 nm | Hepatocytes | Liver | ( |
| BMP-2-[SMCC]-Chitosan | HFIP | / | Osteoblastic MC3T3 cell | Bone | (Park, |
| Gelatin-[EDAC]-PCL | Chloroform/DMF (70:30) | 200–1000 nm | Endothelial cells | Blood vessel | ( |
| Fibronectin-PLLC | HFIP | 100–500 nm | Porcine esophageal epithelial cells | esophagus | ( |
| RGD-(PLGA-b-PEG-NH2)/PLGA | DMF/THF (1:1) | 449 ± 150 nm | NIH3T3 fibroblasts | / | ( |
| PlnDI-collagen (or gelatin) | HFIP | 2–6 μm | MG63 osteoblastic cells | Bone | ( |
Abbreviations: BMP-2, bone morphogenetic protein-2; DCM, dichloromethane; DMF, N,N-dimethyl formamide; EDAC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride; HCAEC, human coronary artery endothelial cell; HCl, Hydrochloric acid; PAAc, poly(acrylic acid); PCL, poly(ɛ-caprolactone); PCLEEP, poly(e-caprolactone-co-ethyl ethylene phosphate); PET, poly(ethylene terephthalate); PlnDI, perlecan domain I; PLGA, poly(D,L-lactic-co-glycolic acid); PLLC, poly(L-lactide-co-caprolactone); PMAA, poly(methacrylic acid); SMCC, succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate; RGD, Arg-Gly-Asp; TFA, trifluoroacetic acid; THF, tetrahydrofuran.
Figure 6Schematic illustration showing the formation of larger pores by electrospinning of mingled nanofibers and in situ leaching out of the water soluble nanofibers (red lines) during cell cultivation (Zhang 2004).
Figure 7Confocal laser scanning micrographs of electrospun mingled fibrous structure of SPU/PEO. (a) Bottom region of the mixed fiber mesh. SPU and PEO were stained with rhodamine and FITC, respectively. (b) Middle region of the mesh observed at the 4 μm-upper region than (a). (c) Top region of the mesh observed at the 4 μm-upper region than (b) (Kidoaki, Kwon et al 2005). Scale bar 10 μm